vs
Side-by-side financial comparison of Inspirato Inc (ISPO) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $55.5M, roughly 1.7× Inspirato Inc). Vericel Corp runs the higher net margin — 25.0% vs -8.1%, a 33.2% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs -19.6%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $-3.0M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs -11.4%).
Inspirato Inc is a luxury travel and hospitality subscription service provider catering primarily to high-net-worth consumers across North America. It offers curated premium villa rentals, exclusive resort access, customized trip planning, and corporate travel incentive solutions for enterprise clients.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
ISPO vs VCEL — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.5M | $92.9M |
| Net Profit | $-4.5M | $23.2M |
| Gross Margin | 31.4% | 78.7% |
| Operating Margin | -8.0% | 24.1% |
| Net Margin | -8.1% | 25.0% |
| Revenue YoY | -19.6% | 23.3% |
| Net Profit YoY | -204.4% | 17.3% |
| EPS (diluted) | $-0.36 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $92.9M | ||
| Q3 25 | $55.5M | $67.5M | ||
| Q2 25 | $63.1M | $63.2M | ||
| Q1 25 | $65.9M | $52.6M | ||
| Q4 24 | $63.1M | $75.4M | ||
| Q3 24 | $69.1M | $57.9M | ||
| Q2 24 | $67.4M | $52.7M | ||
| Q1 24 | $80.2M | $51.3M |
| Q4 25 | — | $23.2M | ||
| Q3 25 | $-4.5M | $5.1M | ||
| Q2 25 | $-5.3M | $-553.0K | ||
| Q1 25 | $1.6M | $-11.2M | ||
| Q4 24 | $-2.3M | $19.8M | ||
| Q3 24 | $4.3M | $-901.0K | ||
| Q2 24 | $-8.7M | $-4.7M | ||
| Q1 24 | $1.3M | $-3.9M |
| Q4 25 | — | 78.7% | ||
| Q3 25 | 31.4% | 73.5% | ||
| Q2 25 | 27.5% | 73.7% | ||
| Q1 25 | 38.8% | 69.0% | ||
| Q4 24 | 34.7% | 77.6% | ||
| Q3 24 | 71.5% | 71.9% | ||
| Q2 24 | 24.0% | 69.5% | ||
| Q1 24 | 39.5% | 68.9% |
| Q4 25 | — | 24.1% | ||
| Q3 25 | -8.0% | 5.1% | ||
| Q2 25 | -8.3% | -3.2% | ||
| Q1 25 | 2.5% | -24.3% | ||
| Q4 24 | -3.2% | 24.5% | ||
| Q3 24 | 9.8% | -4.3% | ||
| Q2 24 | -22.8% | -11.5% | ||
| Q1 24 | 3.0% | -10.7% |
| Q4 25 | — | 25.0% | ||
| Q3 25 | -8.1% | 7.5% | ||
| Q2 25 | -8.4% | -0.9% | ||
| Q1 25 | 2.5% | -21.4% | ||
| Q4 24 | -3.6% | 26.3% | ||
| Q3 24 | 6.3% | -1.6% | ||
| Q2 24 | -12.9% | -8.9% | ||
| Q1 24 | 1.6% | -7.5% |
| Q4 25 | — | $0.46 | ||
| Q3 25 | $-0.36 | $0.10 | ||
| Q2 25 | $-0.42 | $-0.01 | ||
| Q1 25 | $0.12 | $-0.23 | ||
| Q4 24 | $0.98 | $0.40 | ||
| Q3 24 | $0.62 | $-0.02 | ||
| Q2 24 | $-2.33 | $-0.10 | ||
| Q1 24 | $-0.18 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.7M | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-134.0M | $354.6M |
| Total Assets | $228.3M | $488.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $137.5M | ||
| Q3 25 | $13.7M | $135.4M | ||
| Q2 25 | $16.7M | $116.9M | ||
| Q1 25 | $16.4M | $112.9M | ||
| Q4 24 | $21.8M | $116.2M | ||
| Q3 24 | $13.5M | $101.7M | ||
| Q2 24 | $18.8M | $102.5M | ||
| Q1 24 | $22.6M | $110.6M |
| Q4 25 | — | $354.6M | ||
| Q3 25 | $-134.0M | $321.9M | ||
| Q2 25 | $-129.7M | $306.8M | ||
| Q1 25 | $-125.2M | $295.5M | ||
| Q4 24 | $-129.9M | $292.0M | ||
| Q3 24 | $-134.6M | $257.5M | ||
| Q2 24 | $-35.2M | $243.0M | ||
| Q1 24 | $-27.5M | $233.9M |
| Q4 25 | — | $488.0M | ||
| Q3 25 | $228.3M | $453.3M | ||
| Q2 25 | $252.6M | $435.6M | ||
| Q1 25 | $270.1M | $424.6M | ||
| Q4 24 | $273.9M | $432.7M | ||
| Q3 24 | $273.3M | $390.4M | ||
| Q2 24 | $301.7M | $376.8M | ||
| Q1 24 | $313.0M | $356.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.2M | $15.0M |
| Free Cash FlowOCF − Capex | $-3.0M | $12.8M |
| FCF MarginFCF / Revenue | -5.4% | 13.8% |
| Capex IntensityCapex / Revenue | 1.4% | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $-31.2M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $15.0M | ||
| Q3 25 | $-2.2M | $22.1M | ||
| Q2 25 | $1.1M | $8.2M | ||
| Q1 25 | $-6.6M | $6.6M | ||
| Q4 24 | $-15.8M | $22.2M | ||
| Q3 24 | $-13.7M | $10.2M | ||
| Q2 24 | $-1.8M | $18.5M | ||
| Q1 24 | $-7.2M | $7.2M |
| Q4 25 | — | $12.8M | ||
| Q3 25 | $-3.0M | $19.5M | ||
| Q2 25 | $468.0K | $81.0K | ||
| Q1 25 | $-7.5M | $-7.6M | ||
| Q4 24 | $-21.2M | $8.5M | ||
| Q3 24 | $-14.8M | $-9.2M | ||
| Q2 24 | $-3.7M | $1.8M | ||
| Q1 24 | $-8.5M | $-6.8M |
| Q4 25 | — | 13.8% | ||
| Q3 25 | -5.4% | 28.8% | ||
| Q2 25 | 0.7% | 0.1% | ||
| Q1 25 | -11.4% | -14.5% | ||
| Q4 24 | -33.7% | 11.2% | ||
| Q3 24 | -21.5% | -15.9% | ||
| Q2 24 | -5.5% | 3.4% | ||
| Q1 24 | -10.6% | -13.3% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | 1.4% | 3.9% | ||
| Q2 25 | 1.0% | 12.9% | ||
| Q1 25 | 1.3% | 27.0% | ||
| Q4 24 | 8.7% | 18.3% | ||
| Q3 24 | 1.6% | 33.5% | ||
| Q2 24 | 2.8% | 31.8% | ||
| Q1 24 | 1.6% | 27.3% |
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 4.35× | ||
| Q2 25 | — | — | ||
| Q1 25 | -4.09× | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | -3.16× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -5.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ISPO
| Residence And Hotel Travel | $25.9M | 47% |
| Subscription | $19.4M | 35% |
| Experiences And Bespoke Travel | $8.0M | 14% |
| Rewards And Other Revenue | $2.3M | 4% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
